Charles Schwab Investment Management Inc Citius Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 76,073 shares of CTXR stock, worth $39,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,073
Previous 356,994
78.69%
Holding current value
$39,557
Previous $321,000
86.29%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
30.6MCall Options Held
24.7KPut Options Held
0-
Armistice Capital, LLC New York, NY10.2MShares$5.28 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$3.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$938,9770.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.65MShares$856,0740.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $76M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...